Home › Companies › PTC THERAPEUTICS INC. › 2023-2024
Compiled from SEC Form N-PX filings and PTC THERAPEUTICS INC.’s Form 8-K, filed June 20, 2024 (Item 5.07 on EDGAR). Page generated October 25, 2026.
Meeting of June 18, 2024: 4 items on PTC THERAPEUTICS INC.’s Form 8-K, filed June 20, 2024: 4 without a stated outcome.
None.
Material dissent: a director nominee under 80% of the votes cast, say-on-pay under 70%, any other item the board put forward under 80%, or a shareholder proposal with more than 50%, on the company’s own Form 8-K tally. How this is decided
Explore PTC THERAPEUTICS INC. in the interactive database Compare manager voting policies
These tallies are PTC THERAPEUTICS INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed June 20, 2024 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Support (of votes cast) | Reported outcome | Voting standard |
|---|---|---|---|---|---|---|---|---|
| Elect Director: Emma Reeve | 63,383,975 | -- | -- | 2,829,938 | 4,104,129 | 96% | Not verified | — |
| Elect Director: Michael Schmertzler | 64,029,610 | -- | -- | 2,184,303 | 4,104,129 | 97% | Not verified | — |
| Elect Director: Mary Smith | 64,717,219 | -- | -- | 1,496,694 | 4,104,129 | 98% | Not verified | — |
| Elect Director: Glenn D. Steele, Jr., M.D., Ph.D. | 64,598,479 | -- | -- | 1,615,434 | 4,104,129 | 98% | Not verified | — |
Source: PTC THERAPEUTICS INC., Form 8-K, filed with the SEC on June 20, 2024 — read the filing on EDGAR.
Each item below shows how the 208 asset managers that disclosed a PTC THERAPEUTICS INC. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of PTC THERAPEUTICS INC.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.
Combines 3 wordings of this item as funds reported it.
96% Majority: yes · of votes cast
Description as filed by funds: Election of Four Class II Directors: Emma Reeve
PTC THERAPEUTICS INC.’s own tally for this item (“Elect Director: Emma Reeve”): 63,383,975 for, 2,829,938 withheld, per its Form 8-K filed June 20, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 96% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 68 asset managers below reported 27,740,840 for, 636,267 withheld.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 12,562,259 | 0 | 0 | 0 | For |
| Hartford | 2,644,661 | 0 | 0 | 0 | For |
| Fidelity | 2,561,241 | 0 | 0 | 0 | For |
| State Street | 2,276,216 | 0 | 0 | 247 | For |
| First Trust | 1,493,029 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 1,279,907 | 0 | 0 | 0 | For |
| BlackRock | 1,250,204 | 0 | 0 | 0 | For |
| Charles Schwab | 621,210 | 0 | 0 | 0 | For |
| FRANKLIN STRATEGIC SERIES | 480,611 | 0 | 0 | 0 | For |
| T. Rowe Price | 0 | 0 | 0 | 471,935 | Withhold |
| TIAA | 453,589 | 0 | 0 | 0 | For |
| Northwestern Mutual | 346,916 | 0 | 0 | 0 | For |
| Equitable | 110,666 | 0 | 0 | 86,200 | Mixed |
| Direxion Shares ETF Trust | 168,852 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 134,307 | 0 | 0 | 0 | For |
| New York Life | 134,260 | 0 | 0 | 0 | For |
| Russell Investments | 115,013 | 0 | 0 | 0 | For |
| JPMorgan | 89,935 | 0 | 0 | 0 | For |
| Lincoln Financial | 79,319 | 0 | 0 | 0 | For |
| Nationwide | 77,570 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 68,268 | 0 | 0 | 0 | For |
| ProShares | 61,937 | 0 | 0 | 0 | For |
| John Hancock | 60,064 | 0 | 0 | 0 | For |
| Global X | 58,426 | 0 | 0 | 0 | For |
| Brighthouse | 4,075 | 0 | 0 | 38,331 | Mixed |
Showing the 25 largest of 68 asset managers. See all 68 in the interactive database.
Combines 4 wordings of this item as funds reported it.
98% Majority: yes · of votes cast
Description as filed by funds: Election of Four Class II Directors: Glenn D. Steele, Jr., M.D., Ph.D.
PTC THERAPEUTICS INC.’s own tally for this item (“Elect Director: Glenn D. Steele, Jr., M.D., Ph.D.”): 64,598,479 for, 1,615,434 withheld, per its Form 8-K filed June 20, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 98% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 68 asset managers below reported 27,740,840 for, 636,267 withheld.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 12,562,259 | 0 | 0 | 0 | For |
| Hartford | 2,644,661 | 0 | 0 | 0 | For |
| Fidelity | 2,561,241 | 0 | 0 | 0 | For |
| State Street | 2,276,216 | 0 | 0 | 247 | For |
| First Trust | 1,493,029 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 1,279,907 | 0 | 0 | 0 | For |
| BlackRock | 1,250,204 | 0 | 0 | 0 | For |
| Charles Schwab | 621,210 | 0 | 0 | 0 | For |
| FRANKLIN STRATEGIC SERIES | 480,611 | 0 | 0 | 0 | For |
| T. Rowe Price | 0 | 0 | 0 | 471,935 | Withhold |
| TIAA | 453,589 | 0 | 0 | 0 | For |
| Northwestern Mutual | 346,916 | 0 | 0 | 0 | For |
| Equitable | 110,666 | 0 | 0 | 86,200 | Mixed |
| Direxion Shares ETF Trust | 168,852 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 134,307 | 0 | 0 | 0 | For |
| New York Life | 134,260 | 0 | 0 | 0 | For |
| Russell Investments | 115,013 | 0 | 0 | 0 | For |
| JPMorgan | 89,935 | 0 | 0 | 0 | For |
| Lincoln Financial | 79,319 | 0 | 0 | 0 | For |
| Nationwide | 77,570 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 68,268 | 0 | 0 | 0 | For |
| ProShares | 61,937 | 0 | 0 | 0 | For |
| John Hancock | 60,064 | 0 | 0 | 0 | For |
| Global X | 58,426 | 0 | 0 | 0 | For |
| Brighthouse | 4,075 | 0 | 0 | 38,331 | Mixed |
Showing the 25 largest of 68 asset managers. See all 68 in the interactive database.
Combines 3 wordings of this item as funds reported it.
98% Majority: yes · of votes cast
Description as filed by funds: Election of Four Class II Directors: Mary Smith
PTC THERAPEUTICS INC.’s own tally for this item (“Elect Director: Mary Smith”): 64,717,219 for, 1,496,694 withheld, per its Form 8-K filed June 20, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 98% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 68 asset managers below reported 27,740,840 for, 636,267 withheld.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 12,562,259 | 0 | 0 | 0 | For |
| Hartford | 2,644,661 | 0 | 0 | 0 | For |
| Fidelity | 2,561,241 | 0 | 0 | 0 | For |
| State Street | 2,276,216 | 0 | 0 | 247 | For |
| First Trust | 1,493,029 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 1,279,907 | 0 | 0 | 0 | For |
| BlackRock | 1,250,204 | 0 | 0 | 0 | For |
| Charles Schwab | 621,210 | 0 | 0 | 0 | For |
| FRANKLIN STRATEGIC SERIES | 480,611 | 0 | 0 | 0 | For |
| T. Rowe Price | 0 | 0 | 0 | 471,935 | Withhold |
| TIAA | 453,589 | 0 | 0 | 0 | For |
| Northwestern Mutual | 346,916 | 0 | 0 | 0 | For |
| Equitable | 110,666 | 0 | 0 | 86,200 | Mixed |
| Direxion Shares ETF Trust | 168,852 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 134,307 | 0 | 0 | 0 | For |
| New York Life | 134,260 | 0 | 0 | 0 | For |
| Russell Investments | 115,013 | 0 | 0 | 0 | For |
| JPMorgan | 89,935 | 0 | 0 | 0 | For |
| Lincoln Financial | 79,319 | 0 | 0 | 0 | For |
| Nationwide | 77,570 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 68,268 | 0 | 0 | 0 | For |
| ProShares | 61,937 | 0 | 0 | 0 | For |
| John Hancock | 60,064 | 0 | 0 | 0 | For |
| Global X | 58,426 | 0 | 0 | 0 | For |
| Brighthouse | 4,075 | 0 | 0 | 38,331 | Mixed |
Showing the 25 largest of 68 asset managers. See all 68 in the interactive database.
Combines 3 wordings of this item as funds reported it.
97% Majority: yes · of votes cast
Description as filed by funds: Election of Four Class II Directors: Michael Schmertzler
PTC THERAPEUTICS INC.’s own tally for this item (“Elect Director: Michael Schmertzler”): 64,029,610 for, 2,184,303 withheld, per its Form 8-K filed June 20, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 97% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 68 asset managers below reported 27,720,683 for, 649,886 withheld, 6,538 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 12,562,259 | 0 | 0 | 0 | For |
| Hartford | 2,644,661 | 0 | 0 | 0 | For |
| Fidelity | 2,561,241 | 0 | 0 | 0 | For |
| State Street | 2,275,565 | 0 | 0 | 898 | For |
| First Trust | 1,493,029 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 1,279,907 | 0 | 0 | 0 | For |
| BlackRock | 1,250,204 | 0 | 0 | 0 | For |
| Charles Schwab | 621,210 | 0 | 0 | 0 | For |
| FRANKLIN STRATEGIC SERIES | 480,611 | 0 | 0 | 0 | For |
| T. Rowe Price | 0 | 0 | 0 | 471,935 | Withhold |
| TIAA | 453,589 | 0 | 0 | 0 | For |
| Northwestern Mutual | 346,916 | 0 | 0 | 0 | For |
| Equitable | 110,666 | 0 | 0 | 86,200 | Mixed |
| Direxion Shares ETF Trust | 168,852 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 134,307 | 0 | 0 | 0 | For |
| New York Life | 134,260 | 0 | 0 | 0 | For |
| Russell Investments | 115,013 | 0 | 0 | 0 | For |
| JPMorgan | 89,935 | 0 | 0 | 0 | For |
| Lincoln Financial | 79,319 | 0 | 0 | 0 | For |
| Nationwide | 77,570 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 68,268 | 0 | 0 | 0 | For |
| ProShares | 61,937 | 0 | 0 | 0 | For |
| John Hancock | 60,064 | 0 | 0 | 0 | For |
| Global X | 58,426 | 0 | 0 | 0 | For |
| Brighthouse | 4,075 | 0 | 0 | 38,331 | Mixed |
Showing the 25 largest of 68 asset managers. See all 68 in the interactive database.
Combines 10 wordings of this item as funds reported it.
99% Fund and manager reports combined; may count the same shares twice · no official result
Description as filed by funds: Approval on a non-binding, advisory basis, of the Company's named executive officer compensation as described in the proxy statement.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice). The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 12,562,259 | 0 | 0 | 0 | For |
| Hartford | 2,644,661 | 0 | 0 | 0 | For |
| Fidelity | 2,561,241 | 0 | 0 | 0 | For |
| State Street | 2,276,463 | 0 | 0 | 0 | For |
| First Trust | 1,493,029 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 1,279,907 | 0 | 0 | 0 | For |
| BlackRock | 1,250,204 | 0 | 0 | 0 | For |
| Charles Schwab | 621,210 | 0 | 0 | 0 | For |
| FRANKLIN STRATEGIC SERIES | 480,611 | 0 | 0 | 0 | For |
| T. Rowe Price | 471,935 | 0 | 0 | 0 | For |
| TIAA | 453,589 | 0 | 0 | 0 | For |
| Northwestern Mutual | 346,916 | 0 | 0 | 0 | For |
| Equitable | 196,866 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 168,852 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 134,307 | 0 | 0 | 0 | For |
| New York Life | 134,260 | 0 | 0 | 0 | For |
| Russell Investments | 115,013 | 0 | 0 | 0 | For |
| JPMorgan | 89,935 | 0 | 0 | 0 | For |
| Lincoln Financial | 79,319 | 0 | 0 | 0 | For |
| Nationwide | 77,570 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 0 | 68,268 | 0 | 0 | Against |
| ProShares | 61,937 | 0 | 0 | 0 | For |
| John Hancock | 60,064 | 0 | 0 | 0 | For |
| Global X | 58,426 | 0 | 0 | 0 | For |
| Brighthouse | 29,116 | 0 | 13,290 | 0 | Mixed |
Fund voting reports, all 69 managers: 28,297,058 for, 78,725 against, 13,290 abstained. Showing the 25 largest; see all in the interactive database.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Wellington | 8,252,924 | 0 | 0 | 0 | For |
| RTW INVESTMENTS, LP | 7,252,167 | 0 | 0 | 0 | For |
| ARMISTICE CAPITAL, LLC | 4,771,367 | 0 | 0 | 0 | For |
| Camber Capital Management LP | 4,000,000 | 0 | 0 | 0 | For |
| State Street | 3,489,292 | 0 | 0 | 0 | For |
| Janus Henderson | 2,974,624 | 0 | 0 | 0 | For |
| BlackRock | 2,769,037 | 0 | 0 | 0 | For |
| Fidelity | 1,721,773 | 0 | 0 | 0 | For |
| FRANKLIN ADVISERS INC | 1,396,000 | 0 | 0 | 0 | For |
| HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND | 1,313,500 | 0 | 0 | 0 | For |
| GEODE CAPITAL MANAGEMENT, LLC | 1,225,033 | 0 | 0 | 0 | For |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 1,180,897 | 0 | 0 | 0 | For |
| DE Shaw | 764,679 | 0 | 0 | 0 | For |
| Charles Schwab | 621,210 | 0 | 0 | 0 | For |
| Northern Trust | 614,270 | 49 | 0 | 0 | For |
| T. Rowe Price | 608,837 | 0 | 0 | 0 | For |
| Nuveen | 456,660 | 0 | 0 | 0 | For |
| ROCKEFELLER FINANCIAL LLC | 438,419 | 0 | 0 | 0 | For |
| PICTET ASSET MANAGEMENT SA | 398,116 | 0 | 0 | 0 | For |
| BNP Paribas Asset Management Holding S.A. | 0 | 394,727 | 0 | 0 | Against |
| Vanguard | 267,867 | 0 | 0 | 0 | For |
| Two Sigma | 215,461 | 0 | 0 | 0 | For |
| Rafferty Asset Management, LLC | 168,852 | 0 | 0 | 0 | For |
| BANK OF AMERICA NA | 163,984 | 0 | 0 | 0 | For |
| MELLON INVESTMENTS Corp | 124,181 | 0 | 0 | 0 | For |
Institutional-manager reports, all 161 managers: 46,848,887 for, 714,807 against, 113,766 abstained, 60 not voted. Showing the 25 largest; see all in the interactive database.
Combines 3 wordings of this item as funds reported it.
99.9% of fund votes cast · no official result
Description as filed by funds: RATIFICATION OF THE APPOINTMENT OF ERNST & YOUNG LLP AS THE COMPANY'S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2024.
The 69 asset managers below reported 28,375,424 for, 359 against, 13,290 abstained. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 12,562,259 | 0 | 0 | 0 | For |
| Hartford | 2,644,661 | 0 | 0 | 0 | For |
| Fidelity | 2,561,241 | 0 | 0 | 0 | For |
| State Street | 2,276,104 | 359 | 0 | 0 | For |
| First Trust | 1,493,029 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 1,279,907 | 0 | 0 | 0 | For |
| BlackRock | 1,250,204 | 0 | 0 | 0 | For |
| Charles Schwab | 621,210 | 0 | 0 | 0 | For |
| FRANKLIN STRATEGIC SERIES | 480,611 | 0 | 0 | 0 | For |
| T. Rowe Price | 471,935 | 0 | 0 | 0 | For |
| TIAA | 453,589 | 0 | 0 | 0 | For |
| Northwestern Mutual | 346,916 | 0 | 0 | 0 | For |
| Equitable | 196,866 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 168,852 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 134,307 | 0 | 0 | 0 | For |
| New York Life | 134,260 | 0 | 0 | 0 | For |
| Russell Investments | 115,013 | 0 | 0 | 0 | For |
| JPMorgan | 89,935 | 0 | 0 | 0 | For |
| Lincoln Financial | 79,319 | 0 | 0 | 0 | For |
| Nationwide | 77,570 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 68,268 | 0 | 0 | 0 | For |
| ProShares | 61,937 | 0 | 0 | 0 | For |
| John Hancock | 60,064 | 0 | 0 | 0 | For |
| Global X | 58,426 | 0 | 0 | 0 | For |
| Brighthouse | 29,116 | 0 | 13,290 | 0 | Mixed |
Showing the 25 largest of 69 asset managers. See all 69 in the interactive database.
Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 76,696,785 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Vanguard | 16.38% |
| 2 | Hartford | 3.45% |
| 3 | Fidelity | 3.34% |
| 4 | State Street | 2.97% |
| 5 | First Trust | 1.95% |
| 6 | JANUS INVESTMENT FUND | 1.67% |
| 7 | BlackRock | 1.63% |
| 8 | Charles Schwab | 0.81% |
| 9 | FRANKLIN STRATEGIC SERIES | 0.63% |
| 10 | T. Rowe Price | 0.62% |
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Wellington | 10.76% |
| 2 | RTW INVESTMENTS, LP | 9.46% |
| 3 | ARMISTICE CAPITAL, LLC | 6.22% |
| 4 | Camber Capital Management LP | 5.22% |
| 5 | State Street | 4.55% |
| 6 | Janus Henderson | 3.88% |
| 7 | BlackRock | 3.61% |
| 8 | Fidelity | 2.24% |
| 9 | FRANKLIN ADVISERS INC | 1.82% |
| 10 | HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND | 1.71% |
As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row names its form.
| Holder | % outstanding | Disclosure |
|---|---|---|
| Wellington Management | 11.61% | 13F |
| Vanguard Group | 10.81% | 13F |
| RTW Investments, LP | 9.68% | DEF14A |
| BlackRock | 9.30% | 13F |
| Armistice Capital, LLC | 8.95% | DEF14A |
| State Street | 5.36% | 13F |
| Camber Capital Management LP | 5.22% | DEF14A |
| Michael Schmertzler | 2.25% | DEF14A |
| Geode Capital | 2.17% | 13F |
| FMR (Fidelity) | 2.10% | 13F |
Percentages above are of 76,696,785 shares outstanding, as reported by PTC THERAPEUTICS INC. on its Form 10-Q dated April 23, 2024 (see the filing on EDGAR). This is the count contemporaneous with the 2023-2024 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from PTC THERAPEUTICS INC.’s 10-Q dated April 23, 2024. This page is a static snapshot rebuilt weekly on October 25, 2026; a live search always shows the current data.
At PTC THERAPEUTICS INC.'s shareholder meeting held June 18, 2024, in the 2023-2024 proxy season, 208 asset managers reported how they voted in their SEC Form N-PX filings, covering 1,700 separate fund positions. Their filings are grouped here into 6 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. PTC THERAPEUTICS INC.'s own Form 8-K tally for this meeting is published below, but no row in it could be matched to the most widely held item, so this page states no certified outcome for that item. On that item — Approval on a non-binding, advisory basis, of the Company's named executive officer… — the reporting funds and managers cast 99% of the shares they voted in favour (FOR divided by FOR plus AGAINST plus WITHHELD; abstained and unvoted shares are excluded because neither took a side). Fund and manager reports are combined in it and may count the same shares twice: it adds fund reports to institutional-manager reports, which can cover the same shares. It is not the company's certified result.
PTC THERAPEUTICS INC. proxy season coverage: 2023-2024 (this page) · 2024-2025 · 2025-2026.
Download data (CSV): ballot items · votes by manager · column guide.